Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Now we know how Atkins diet works!

Researchers now know how the low-carb Atkins diet takes off the extra pounds and that knowledge is surprising!

16 Mar 2005

Questions about validity of HOPE TOO vitamin E study

A study published in the March 16 issue of Journal of the American Medical Association (JAMA) suggesting that a "daily-dose" of vitamin E (400 international units) among high-risk (chronically ill) cardiovascular patient populations is associated with a greater risk of heart failure is being challenged by leading health researchers around the country who claim the study lacks the adequate research and controlled sampling audience to justify this conclusion.

16 Mar 2005

Q. What turns an obese person into a person with diabetes? - A. Leptin

Twin epidemics of obesity and type 2 diabetes are bearing down on the world's population, threatening the lives of hundreds of millions of people. But scientists are still trying to determine how the two conditions are linked, and what it takes to turn an obese person into a person with diabetes.

16 Mar 2005

ViaCell and Genzyme announce collaboration - ViaCell announces patent issuance

ViaCell and Genzyme Corporation announced today that the two companies entered into a collaboration related to diabetes.

15 Mar 2005

New study regarding Atkins nutritional approach and obese patients

A new study by Temple University School of Medicine researchers has shown why the pounds melt so quickly on low-carbohydrate diets, and it's not related to water, metabolism or boredom. The research was conducted in a group of obese patients with type 2 diabetes who followed the Atkins diet.

14 Mar 2005

Diabetes "cured" by transplant

61-year-old businessman and community activist, Richard Lane, has become Britain's first fully successful islet cell transplant recipient.

9 Mar 2005

Insulin levels linked to Alzheimer's disease

Insulin and its related proteins are produced in the brain, and according to researchers from Rhode Island Hospital and Brown Medical School, reduced levels of this combination can be linked to Alzheimer's disease. The findings are reported in the March issue of the Journal of Alzheimer's Disease.

7 Mar 2005

FDA has accepts new drug application for Exubera (inhaled human insulin powder)

Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).

3 Mar 2005

CPAP therapy helps control glucose levels among patients with Type II diabetes and sleep apnea

Patients with Type II diabetes who also suffer from obstructive sleep apnea can lower their glucose levels by receiving the most common sleep apnea therapy, a new study has found.

1 Mar 2005

First study to show cost-effectiveness of pre-diabetes intervention

More than 40 million Americans face a high risk of developing Type 2 diabetes, and it would cost a lot to give all of them intensive help with diet and exercise, or medication, to keep them from developing diabetes.

28 Feb 2005

Childhood obesity is a serious health problem in Australia

Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.

24 Feb 2005

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Scientists at the University of Maryland School of Medicine in Baltimore have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease.

23 Feb 2005

Prozac, Xenical and Meridia may help type 2 diabetes patients lose weight

Three commonly used drugs - Prozac, Xenical and Meridia - may help type 2 diabetes patients lose small amounts of weight, although long-term benefits are not clear, a new review of 22 studies suggests.

20 Feb 2005

Olmesartan improves blood supply to kidneys

How do medications that block the renin-angiotensin system (RAS blockers) work to protect against kidney disease in people with diabetes? At least partly by improving the blood supply to the kidneys, suggests a study in the April Journal of the American Society of Nephrology.

17 Feb 2005

Link between diabetes and obesity

Scientists at Washington University School of Medicine in St. Louis used genetically modified mice to uncover a potentially important link between diabetes and obesity.

15 Feb 2005

Scientists show knocking out key signals will cause diabetes

Using a revolutionary technique to turn off chemical signals inside the cell, scientists at Joslin Diabetes Center have discovered that the different metabolic abnormalities present in type 2 diabetes can be caused by knocking out two key signals in liver cells.

11 Feb 2005

Short girls with underlying disease are not being diagnosed

Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.

7 Feb 2005

Cardiac rehabilitation and secondary prevention protocols to imperative prevent recurrent heart attacks

Physicians should aggressively encourage patients to exercise and follow cardiac rehabilitation and secondary prevention protocols to prevent recurrent heart attacks, the American Heart Association recommends in its updated scientific statement on cardiac rehabilitation and secondary prevention of coronary heart disease.

27 Jan 2005

Major health problems in babies of diabetic mothers on the rise

During the past decade, babies born to women with type 2 diabetes have shown an increasing number of serious health problems -- including stillbirth and birth defects, such as brain, spine and heart congenital malformations that can lead to infant deaths, according to a study published in the February issue of Diabetes Care.

27 Jan 2005

Lack of the enzyme acetyl CoA carboxylase 2 turns fat cells into fat burners

Lack of the enzyme, acetyl CoA carboxylase 2 or ACC2, appears to turn the adipose or fat cells of mice into fat burners, explaining in part why the animals can eat more and weigh less than their normal counterparts, said Baylor College of Medicine researchers.

25 Jan 2005